← Bioventus Inc. BVS
Market Price
$14.27
Market Cap
$941.70M
P/E Ratio
N/A
Revenue (FY 2025)
↓-0.9% YoY
$568.09M
3-Yr CAGR: 3.5%
Net Income
↑162.2% YoY
$27.27M
Net Margin: 4.8%
Free Cash Flow
↑92.1% YoY
$74.43M
FCF Yield: 7.90%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
14.8%
ROA: 4.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (BVS)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2019 | $340.1M | — | $249.2M | $8.1M | — | — | — | $42.5M | $42.5M | — |
| FY 2020 | $321.2M | -5.6% | $233.5M | $14.7M | +81.5% | — | — | $72.2M | $71.9M | +69.0% |
| FY 2021 | $430.9M | +34.2% | $302.7M | $9.6M | -34.9% | — | — | $23.0M | $22.3M | -69.0% |
| FY 2022 | $512.1M | +18.8% | $331.1M | $-144.7M | -1,609.0% | — | — | $-13.5M | $-14.0M | -162.6% |
| FY 2023 | $512.3M | +0.0% | $328.2M | $-121.2M | +16.2% | — | — | $17.5M | $16.2M | +216.1% |
| FY 2024 | $573.3M | +11.9% | $388.2M | $-43.8M | +63.8% | — | — | $38.8M | $38.8M | +139.2% |
| FY 2025 | $568.1M | -0.9% | $388.2M | $27.3M | +162.2% | — | — | $74.7M | $74.4M | +92.1% |
Valuation
Market Price
$14.27
Market Cap
$941.70M
Enterprise Value
$1.17B
P/E Ratio
N/A
P/B Ratio
5.25
FCF Yield
7.90%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
68.33%
Operating Margin
9.50%
Net Margin
4.80%
Return on Equity (ROE)
14.81%
Return on Assets (ROA)
3.99%
Asset Turnover
0.83x
Revenue 3-Yr CAGR
3.52%
Financial Health & Liquidity
Current Ratio
2.63
Cash Ratio
12.17
Debt / Equity
1.515
Debt / Assets
0.408
Cash & Equivalents
$51.24M
Total Debt
$278.95M
Book Value / Share
$2.72
Cash Flow Efficiency
Operating Cash Flow
$74.67M
Capital Expenditures (CapEx)
$240.00K
Free Cash Flow
$74.43M
OCF / Revenue
13.14%
FCF / Revenue
13.10%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$2.72
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$683.56M
Total Liabilities
$683.56M
Stockholders' Equity
$184.10M
Current Assets
$11.06M
Current Liabilities
$4.21M